SNUBI Research ::   (469 talks satisfying Title has 'genomic')
All  Seminar  BioEMR  xMutant  SysBiol  MAInfo  J.Club  TopicSem  BookReading    This week    Help

ADD NEW USER

:   ǥ:    /Ű:    ¥:   

2024-03:
02 차재현 Genomic landscape and prognosis of patients with TP53-mutated non-small cell lung cancer     J.Club
09 조민아 Genomic data in the All of Us Research Program     J.Club
25 Real-world evaluation of the clinical benefits of translating pharmacogenomics knowledge included in the CPIC guidelines  TopicSem
30 안세환 Empowering personalized pharmacogenomics with generative AI solutions     J.Club

2024-02:
24 유준기 cLD Rare variant linkage disequilibrium between genomic regions identifies novel genomic interactions     J.Club
28 유준기 CoxPH model for cross-sectional genomic data  MAInfo

2024-01:
15 이시은 G-CDM : genomic information to current OMOP-CDM  SysBiol

2023-12:
23 안세환 Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank     J.Club

2023-11:
11 조민아 Mexican Biobank advances population and medical genomics of diverse ancestries     J.Club
25 권호식 Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics data     J.Club

2023-10:
18 윤미선 Nine-gene pharmacogenomics profile service  MAInfo
18 윤미선 Nine-gene pharmacogenomics profile service  MAInfo

2023-09:
18 권호식 Candidate genomic variations in patients with adverse reactions to contrast media  TopicSem

2023-08:
23 차재현 genomic studies of ASD  MAInfo
28 권호식 Summary of Results for Pharmacogenomic Study of Contrast media-induced adverse reactions   TopicSem
30 윤미선 Visualizing genomic information across chromosomes with PhenoGram  MAInfo

2023-07:
22 윤미선 The pharmacogenomic landscape of an Indigenous Australian population     J.Club
31 차재현 Genomic study of Major Depressive Disorder  TopicSem

2023-06:
07 유준기 Computational genomic approaches to interpret non-coding disease risk variants  MAInfo

2023-05:
11 전예진 GWAS in complex disease and pharmacogenomics  TopicSem
13 안세환 A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants     J.Club

2023-04:
10 Importance of rare pharmacogenomic variants in interpreting drug response  TopicSem
10 차재현 Analyzing Genomic Data from the 1000 Genomes Project  TopicSem
20 권호식 Potential genomic variations related with adverse effects of contrast media  TopicSem

2023-03:
20 권호식 Potential genomic variations related with adverse effects of contrast media  TopicSem

2023-02:
18 안세환 Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics     J.Club

2023-01:
12 안선주 Pharmacogenomics Watch(PGWatch) - Intro, Terms, DB  TopicSem
30 윤미선 Pharmacogenomic Profile of Korean population using whole genome sequencing (HLA)  TopicSem

2022-12:
03 부은경 An integral genomic signature approach for tailored cancer therapy using genome-wide sequencing data     J.Club
26 윤미선 Pharmacogenomic Profile of Korean population using WGS  TopicSem

2022-11:
19 안세환 PharmaKU: A web-based tool aimed at improving outreach and clinical utility of pharmacogenomics     J.Club

2022-10:
01 배소정 Ultrafast search of all deposited bacterial and viral genomic data     J.Club
01 안세환 Aldy 4:An efficient genotypes and star-allele caller for pharmacygenomics     J.Club
15 ̿ Impact of integrating genomic data into the electronic health record on genetics care delivery     J.Club
15 윤미선 Returning individual genomic results to population‑based cohort study participants with BRCA1/2 pathogenic variants     J.Club
24 윤미선 Pharmacogenomic Profile of Korean population using whole genome sequencing (Methods & Results of HLA)  TopicSem

2022-09:
22 윤미선 Pharmacogenomic Profile of Korean population using whole genome sequencing_2  TopicSem
26 전예진 type of pharmacogenomic evidence and limitation  SysBiol

2022-08:
01 조민아 Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle  SysBiol
08 윤미선 Pharmacogenomic Profile of Korean population using whole genome sequencing_2  TopicSem
20 윤미선 Development of an extensive workflow for comprehensive clinical pharmacogenomic profiling: lessons from a pilot study on 100 whole exome sequencing data     J.Club
27 전예진 Biobank Scale Pharmacogenomics Informs the Genetic Underpinnings of Simvastatin Use     J.Club

2022-07:
23 안세환 Dating genomic variants and shared ancestry in population scale sequencing data     J.Club

2022-06:
04 배소정 Loss of Bacitracin Resistance Due to a Large Genomic Deletion among Bacillus anthracis Strains     J.Club

2022-05:
16 윤미선 Pharmacogenomic Profile of Korean population using whole genome  TopicSem
28 조민아 A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis     J.Club

2022-04:
07 유준기 All of Us: Genomic data browser  MAInfo
09 안세환 Pharmacogenomic landscape of Indian population using whole genomes     J.Club
16 조원일 Automated Pharmacogenomic Reports for Clinical Genome Sequencing     J.Club

2022-02:
12 윤미선 Pharmacogenomic analysis of a genetically distinct Indigenous population     J.Club
19 ӿ The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets     J.Club

2022-01:
11 조민아 Genozip: a universal extensible genomic data compressor  SysBiol
24 인턴 Pharmacogenomics and individualized therapy through VCF analysis     TopicSem

2021-11:
20 ̿ Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer     J.Club

2021-08:
30 조동영 Improving Genomic Discovery with Machine Learning Based Phenotyping  TopicSem

2021-07:
10 홍진희 Estimation of Genetic Correlation via Linkage Disequilibrium Score Regression and Genomic Restricted Maximum Likelihood     J.Club

2021-06:
03 ֿ Genomic variant analysis and interpretation for Parkinsons disease  TopicSem
03 ֿ Genomic variant analysis and interpretation for Parkinsons disease  TopicSem

2021-05:
04 조동영 Pharmacogenomics Application and Challenges  SysBiol
04 조동영 Pharmacogenomics Application and Challenges  SysBiol
08 안세환 Genetic ancestry plays a central role in population pharmacogenomics     J.Club

2021-04:
20 조원일 Review: pharmacogenomics_lancet  SysBiol
26 유경훈 ATAV - a comprehensive platform for population-scale genomic analyses  xMutant

2021-03:
13 안세환 Systems Pharmacogenomic Landscape of Drug Similarities from LINCS data: Drug Association Networks     J.Club
23 ֿ Parkinsons disease Genomic Analysis  Seminar
29 윤미선 Common treatment, common variant: evolutionary prediction of functional pharmacogenomic variants  TopicSem

2021-02:
25 유경훈 Comprehensive analysis to discover the genomic background of antidepressant drug response  TopicSem

2021-01:
02 Genomic sequencing for newborn screening: results of the NC NEXUS project     J.Club

2020-12:
12 조민아 Imaging genomics discovery of a new risk variant for Alzheimer     J.Club

2020-11:
28 ֿ Population structure and pharmacogenomic risk stratification in the United States     J.Club

2020-10:
26 ֿ Examining the impact of pharmacogenomics testing with UK Biobank and its use for ADR risk comparisons  TopicSem

2020-09:
05 김지헌 SWEDEGENE—a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions       J.Club

2020-08:
31 ֿ Identifying populations likely to benefit from pharmacogenomic testing  SysBiol
31 ֿ Implementation of pharmacogenomics via a research biobank  BioEMR

2020-07:
13 ֿ The implementation of pharmacogenomics for older adults  SysBiol
25 ӿ A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer     J.Club
25 ֿ Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients     J.Club

2020-06:
01 유경훈 Genomic variant analysis using thiopurine target panel including 4 genes  TopicSem
08 김지헌 Genomic variant analysis of healthy individuals   TopicSem
20 ȿ An ancillary genomics system to support the return of pharmacogenomic results     J.Club

2020-05:
04 ȿ Pharmacogenomic Clinical Decision Support: Modular Implementation of CPIC Guideline   TopicSem
16 ֿ Pharmacogenomic-Based Decision-Support to Predict Adherence to Medications     J.Club
28 ȿ Pharmacogenomic Clinical Decision Support: Modular Implementation of CPIC Guideline   TopicSem

2020-04:
06 ȿ Pharmacogenomic Clinical Decision Support: Modular Implementation of CPIC Guideline   TopicSem
06 ֿ SWEDEGENE-a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions  BioEMR
06 안세환 The Comparative Toxicogenomics Database  SysBiol
18 ȿ Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare     J.Club
27 ȿ [review] Development of a Genomic Data Flow Framework: Results of a Survey Administered to NIH-NHGRI IGNITE and eMERGE Consortia Participants  SysBiol

2020-03:
02 ȿ [Review] Precision Medicine Is Not Just Genomics: The Right Dose for Every Patient  BioEMR
09 ֿ The design and implementation strategy of European pharmacogenomics through the U-PGx consortium  SysBiol
09 ֿ The design and implementation strategy of European pharmacogenomics through the U-PGx consortium  SysBiol

2020-02:
27 ӿ Identification of genomic markers affecting sentivity of tacrolimus   TopicSem

2020-01:
18 ֿ Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults     J.Club

2019-12:
14 ȿ Genomic Information for Clinicians in the Electronic Health Record: Lessons Learned From the Clinical Genome Resource Project and the Electronic Medical Records and Genomics Network     J.Club

2019-11:
11 Comprehensive genomic analysis for identifying genes related to age of onset in Major Depressive Disorder (MDD) patients  TopicSem
25 한봄 Genomics and electronic health record systems  BioEMR
28 Genomic analysis of L-asparaginase-induced pancreatitis in 25 Korean pediatric ALL patients.  MAInfo

2019-10:
07 Comprehensive genomic analysis for identifying genes related to age of onset in Major Depressive Disorder (MDD) patients  TopicSem
10 유승원 ProteinPaint : Exploring genomic alteration in pediatric cancer using ProteinPaint  xMutant
21 Comprehensive genomic analysis for identifying genes related to age of onset in Major Depressive Disorder (MDD) patients  Seminar
21 Comprehensive genomic characterization of pharmacogenetic, common-disease, and Mendelian-disease genes facilitates the risk gene prioritization.  Seminar
21 Genomic analysis of L-asparaginase-induced pancreatitis in 25 Korean pediatric ALL patients.  Seminar
21 ӿ Identification of genomic markers affecting sentivity of tacrolimus  Seminar
21 권호식 Identification of potential genomic markers related with adverse effects of Contrast Media  Seminar
26 ֿ Analyzing the Clinical Actionability of Germline Pharmacogenomic Findings in Oncology     J.Club
28 권호식 Identification of potential genomic variants related with adverse effects of Contrast Media  TopicSem
31 김재환 Development of Genomic variant Interpretation Assistant Tool (GI-AT)  TopicSem

2019-09:
28 ȿ The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system     J.Club
30 유경훈 Pharmacogenomic genotypes define genetic ancestry in patients and enable population-specific genomic implementation  SysBiol

2019-08:
10 유경훈 Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study     J.Club
12 Comprehensive genomic characterization of pharmacogenetic, common-disease, and Mendelian-disease genes and its applications to gene prioritization.  TopicSem
12 Whole-genome sequencing of rare disease patients in a national healthcare system - Genomics England 100,000 genomes project  SysBiol
24 ֿ Characterizing pharmacogenomic-guided medication use with a clinical data repository     J.Club
26 ȿ [review] Genomic information for clinicians in the EHR: lessons learns from clinGen and eMerge  SysBiol

2019-07:
01 김재환 Current status of Genomic Variant analysis Assistant Tool (GV-AT) SNUBI development  TopicSem
06 부은경 Expanding Parkinsons disease genetics: novel risk loci, genomic context, causal insights and heritable risk     J.Club
15 ȿ [Review] Implementing Genomic Clinical Decision Support for Drug-Based Precision Medicine  BioEMR
15 ȿ [Review] Implementing Genomic Clinical Decision Support for Drug-Based Precision Medicine  BioEMR
27 ȿ A Pharmacogenomics Clinical Decision Support Service Based on FHIR and CDS Hooks      J.Club

2019-06:
01 민유정 .Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study     J.Club
08 ֿ Network, transcriptomic and genomic features differentiate genes relevant for drug response     J.Club
17 κ Genomic variant analysis using leukemia target panel including 11 genes  TopicSem
22 채정환 Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies     J.Club

2019-05:
02 권호식 MTX Genomic markers from literatures  xMutant
11 ȿ Pharmacogenomic clinical decision support design and multi-site process outcomes analysis in the eMERGE Network     J.Club

2019-04:
08 ֿ A disease-drug database to support drug prescribing based on patient pharmacogenomics test results  SysBiol
13 ֿ Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing     J.Club

2019-03:
09 ̿ Re-identification of individuals in genomic data-sharing beacons via allele inference     J.Club

2019-02:
23 안세환 GenIO: a phenotype-genotype analysis web server for clinical genomics of rare diseases     J.Club

2019-01:
19 한봄 Functional annotation of genomic variants in studies of late-onset Alzheimer     J.Club

2018-11:
08 유경훈 Analysis of population-specific pharmacogenomic variants using next-generation sequencing data  SysBiol
17 ֿ Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes     J.Club

2018-09:
01 권호식 The landscape of genomic alterations across childhood cancers     J.Club
08 Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines     J.Club

2018-08:
04 한봄 Applications of pharmacogenomics in regulatory science: a product life cycle review     J.Club
25 안세환 Gene Graphics: a genomic neighborhood data visualization web application     J.Club
25 ȿ Genomic decision support needs in pediatric primary care     J.Club

2018-07:
19 ȿ Genomic Data Model for Clinical Utilization   TopicSem
21 Relationship between Deleterious Variation, Genomic Autozygosity, and Disease Risk: Insights from The 1000 Genomes Project     J.Club
21 κ Germline de novo mutation clusters arise during oocyte aging in genomic regions with high double-strand-break incidence     J.Club

2018-06:
26 Radiogenomics for TNBC: Relationship between Microarray profile and radiomics texture data  xMutant

2018-05:
17 GA4GH and Google genomics  BioEMR
26 ֿ Patient-Centered Precision Health In A Learning Health Care System: Geisingers Genomic Medicine Experience     J.Club

2018-04:
21 ӿ Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics      J.Club

2018-03:
17 정문경 Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer       J.Club

2018-01:
06 Pharmacogenomics of GPCR Drug Targets     J.Club
23 KCDM genome and FHIR genomics  BioEMR

2017-12:
02 Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies     J.Club
16 ֿ Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing     J.Club

2017-11:
02 ȣ SSRIs drugs with Pharmacogenomic snp and adr  SysBiol

2017-10:
14 ֿ Multidisciplinary model to implement pharmacogenomics at the point of care     J.Club

2017-09:
09 ӿ Integrative clinical genomics of metastatic cancer     J.Club
25 ȣ SNRIs Antidepressants and Pharmacogenomic information  SysBiol
25 ȣ SNRIs Antidepressants and Pharmacogenomic information  SysBiol

2017-07:
05 GENIE : Basic characteristics of clinical and genomic data across the various cancer type  MAInfo
08 유경훈 Semantic prioritization of novel causative genomic variants     J.Club
17 SCAN and PACdb : pharmacogenomics databases  SysBiol
17 SCAN and PACdb : pharmacogenomics databases  SysBiol
22 ֿ Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cas     J.Club
26 Validation a Synthetic Dosage Cancer Survival Pairs using a Genomics of Drug Sensitivity in Cancer database  TopicSem

2017-06:
05 Repositories where researchers can download or upload genomic data  SysBiol
10 Pharmacogenomic variants have larger effect sizes than genetic variants associated with other dichotomous complex traits.     J.Club
28 Repositories where researchers can download or upload genomic data   xMutant

2017-05:
27 ֿ Creating a scalable clinical pharmacogenomics service with automated interpretation and medical record result integration-experience from a pediatric tertiary care facility     J.Club

2017-04:
03 ePGA: AWeb-Based Information System for Translational Pharmacogenomics  SysBiol
15 ̿ Fast, scalable prediction of deleterious noncoding variants from functional and population genomic data     J.Club
29 ӿ Reassessment of Genomic Sequence Variation to Harmonize Interpretation for Personalized Medicine     J.Club

2017-03:
08 MEREDITH:Clustering and Visualization tools for TCGA PAN-CANCER with multiplatform genomic data  MAInfo
20 ̰ȭ Review Cases of Genomic Data Warehouse   SysBiol

2017-02:
08 Translating phenotype into a functional gene-level score using Corriell samples Pharmacogenomic genotypes  xMutant
18 ӿ Somatic Mutation Patterns in Hemizygous Genomic Regions Unveil Purifying Selection during Tumor Evolution     J.Club

2017-01:
23 ֿ Chromosomal distribution of variants synthetically associated with pharmacogenomic SNPs  SysBiol
25 Intern (Replication) Genomic and Epigenomic Landscapes of Adult De Novo AML     Seminar

2016-12:
05 Integrative analysis for identifying the best anticancer therapy based on genomic features  SysBiol
24 The global spectrum of protein-coding pharmacogenomic diversity     J.Club

2016-11:
05 ̰ȭ Development of clinical decision support alerts for pharmacogenomic incidental findings from exome sequencing      J.Club
09 ֿ Gene score distribution of genes including or proximate to pharmacogenomic SNPs  TopicSem

2016-10:
17 ȣ Bina - develops next-generation genomic management   SysBiol

2016-09:
19 The human diseases network using genomic information  TopicSem
21 [REVIEW] Mutations and Drugs Portal(MDP) : A database linking drug response data and genomic information   xMutant

2016-08:
06 A Landscape of Pharmacogenomic Interactions in Cancer     J.Club
10 ֿ Finding genomic features that affect drug response  TopicSem
19 ReAlCap (Reads Alignment Capture) : A fast and handy tool for capturing genomic reads  Seminar
19 PharmPortal_A Personal Pharmacogenomics Knowledgebase  Seminar

2016-06:
18 SMART precision cancer medicine a FHIR-based app to provide genomic information at the point of care     J.Club
25 ӿ Characterizing genomic alterations in cancer by complementary functional associations     J.Club

2016-05:
18 Research for investigating genomic characteristics in human disease network  TopicSem

2016-04:
04 Evaluation of filtering strategies to identify disease-associated genomic variants in multiple disease categories.  TopicSem
04 [REVIEW]Public data and open source tools for multi-assay genomic investigation of disease  xMutant
11 Ethical, social and legal issues in pharmacogenomics     SysBiol
29 ӿ Pharmacogenomic agreement between two cancer cell line data sets  MAInfo

2016-03:
01 Genomic intra- and inter-tumor heterogeneity Softwares and post session research  xMutant
19 Personalized Whole-Cell Kinetic Models of Metabolism for Discovery in Genomics and Pharmacodynamics     J.Club
19 ̰ȭ Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach     J.Club

2016-01:
14 ̰ȭ Review:Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data  MAInfo

2015-12:
05 κ Post-zygotic Point Mutations Are an Underrecognized Source of De Novo Genomic Variation     J.Club
12 ֿ Making pharmacogenomic-based prescribing alerts more effective: A scenario-based pilot study with physicians     J.Club
28 Pharmacogenomics: Polymorphic CYPs in Personalized Therapy  TopicSem

2015-11:
14 Cost-Effectiveness of Combinatorial Pharmacogenomic Testing for Treatment-Resistant Major Depressive Disorder Patients     J.Club
21 SMART on FHIR Genomics: Facilitating standardized clinico-genomic apps     J.Club

2015-10:
19 Proposal on Machine Learning Application to Cancer Pharmacogenomics  TopicSem

2015-09:
09 Interest in Study of Genomics of Drug Sensitivity in Cancer  TopicSem
12 ֿ Electronic health record design and implementation for pharmacogenomics: a local perspective     J.Club

2015-08:
29 ӿ Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities     J.Club
29 Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas     J.Club

2015-07:
27 Research on Diabetes and Pharmacogenomics  TopicSem

2015-06:
12 ̰ȭ Review: Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug Reactions  MAInfo
20 κ Cancer genomics: one cell at a time     J.Club

2015-05:
01 ̰ȭ Cancer genomics review  MAInfo
16 ӿ Assessing the clinical utility of cancer genomic and proteomic data across tumor types     J.Club
20 ̼S Personal pharmacogenomics : pharmacological approach based on genomic variant  TopicSem

2015-04:
15 ̼S Personal pharmacogenomics : pharmacological approach based on genomic variant  TopicSem
17 ̰ȭ Review of cancer genomics: Colon cancer  MAInfo
18 Development of a broad-based ADME panel for use in pharmacogenomic studies      J.Club
24 ̰ȭ Review: Genomics of cardiovascular disease  MAInfo

2015-03:
16 ̼S Personal pharmacogenomics : pharmacological approach based on genomic variant  TopicSem

2015-01:
17 In silico comparative characterization of pharmacogenomic missense variants     J.Club
24 Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss     J.Club
26 Pharmportal: pharmacogenomic database integration  TopicSem
26 ̼S Pharmportal :Provide drug information For personal pharmacogenomics interpretation   TopicSem
30 ̰ȭ The importance of phase information for human genomics  MAInfo

2014-12:
13 ֿ Development and use of active clinical decision support for preemptive pharmacogenomics     J.Club

2014-11:
01 Personalized pharmacogenomics profiling using whole-genome sequencing     J.Club
22 Interpretation of Genomic Variants Using a Unified Biological Network Approach     J.Club

2014-10:
11 ̼S Pharmacogenomic characterization of gemcitabine response – a framework for data integration to enable personalized medicine     J.Club
13 NGS panel for Busulfan, COPD, 6MP, ADME Core and pharmacogenomic variants  TopicSem

2014-09:
06 Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas     J.Club
12 ̰ȭ Genomic data privacy and security  MAInfo
12 ̰ȭ Genomic data privacy and security  MAInfo
20 ֿ Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multicenter Pilot for Preemptive Pharmacogenomics in Electronic Health Record Systems     J.Club
20 Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for Pharmacogenomics      J.Club

2014-08:
06 Introduction to Complete Genomics Sequencing Data and CGATools  TopicSem
13 Genomic perturbation on 1000 genomes population   TopicSem
16 ֿ Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol     J.Club

2014-07:
19 Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation     J.Club
26 ISMB review : A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes     J.Club
30 Summary of pharmacogenomic information about busulfan  TopicSem

2014-06:
10 ֿ Review of FDA-approved drugs with pharmacogenomic information in their labeling  SysBiol
14 Heritability and genomics of gene expression in peripheral blood  J.Club

2014-05:
01 ̰ȭ News about Genomics     MAInfo
03 Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients     J.Club
07 ̼S Pharmsafe algorithm accuracy boosting using genomic feature and biological knowledge   TopicSem
24 Personalized genomic disease risk of volunteers     J.Club

2014-04:
03 ̰ȭ Genomic news  MAInfo
05 ̼S Inconsistency in large pharmacogenomic studies     J.Club
07 ̼S Pharmsafe algorithm accuracy boosting using genomic feature and biological knowledge   TopicSem
12 Systematic identification of genomic markers of drug sensitivity in cancer cells     J.Club
28 ֿ Finding genomic factors that regulate drug efficacy  TopicSem
28 Identify ADR causal gene with personal genomic variant profile  TopicSem

2014-03:
12 ̼S SIFT & 1000 genome variant intersection calculation and Pharmsafe algorithm accuracy boosting using genomic feature and biological knowledge   TopicSem
22 Clinically Actionable Genotypes Among 10,000 Patients With Preemptive Pharmacogenomic Testing  J.Club
26 κ Identification of causes of neuropsychiatric disorders by using genomic data  TopicSem

2014-02:
04 Apply CCLE data to personal pharmacogenomics research  SysBiol
10 ̼S Pharmsafe algorithm accuracy boosting using genomic feature and biological knowledge   TopicSem

2014-01:
15 ̼S Pharmsafe algorithm accuracy boosting using genomic feature and biological knowledge   TopicSem
20 The Cancer Cell Line Encyclopedia (CCLE) - review and discussion about its personal pharmacogenomic application  SysBiol
21 Cancer genomics research topics and plans for 2014  xMutant

2013-12:
03 ̼S review of Pharmacogenomics(Pharmacogenomics in Action)  SysBiol
07 ӿ Integrative annotation of variants from 1092 humans: application to cancer genomics.     J.Club

2013-11:
09 Systematic Pharmacogenomics Analysis of Malay Whole Genome : Proof of Concept for Personalized Medicine     J.Club
25 ̼S Pharmsafe algorithm accuracy boosting using genomic feature and biological knowledge   TopicSem
27 ̰ȭ Pharmaceutical market withdrawal prediction through personal genomic sequence variation  TopicSem
30 The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system     J.Club

2013-10:
07 ȼ Clinical Cancer Genomics   TopicSem

2013-09:
30 Genomic Perturbation Network   TopicSem

2013-08:
24 The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems Pharmacology     J.Club

2013-07:
01 ̼S Personal phenotype ranking algorithm based on genomic variation  TopicSem
08 Genomic characterization of drug perturbation sensitivity  TopicSem
12 Genomic characterization of drug perturbation sensitivity  Seminar
12 PharmRank : Personal genome sequence-based pharmacogenomics drug ranking system for potential adverse drug reactions  Seminar
30 Search Strategies in cBioPortal for Cancer Genomics  xMutant

2013-06:
01 integrated genomic characterization of endometrial carcinoma  J.Club
05 ̼S Personal phenotype ranking algorithm based on genomic variation&  TopicSem

2013-05:
06 Personal drug ranking algorithm based on genomic variation  TopicSem
06 κ Genomic analysis of Spondyloepimetaphyseal Dysplasia with Joint Laxity to identify the gene containing the causal mutations  TopicSem
08 Genomic analysis of Retinitis Pigmentosa by using targeted exome capture sequencing  TopicSem
11 Comprehensive genomic characterization defines human glioblastoma genes and core pathways     J.Club
13 ̼S Personal phenotype ranking prediction based on genomic variation  TopicSem
25 ̰ȭ Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia  J.Club

2013-04:
15 Medappllo : Drug ranking forecast algorithm based on personal genomic variation  TopicSem
17 ̼S PRAGEN : personal Phenotype Ranking Algorithm based on GENomic variation  TopicSem

2013-03:
16 Genomic Variation landscape of the human gut microbiome      J.Club

2013-02:
04 Knowledge bootstrapping: A graph-based integration with multi-omics data and genomic knowledge  Seminar
05 MedCassandra : Drug and ADR ranking forecast system based on personal genomic variation  Seminar
09 GenePING : secure, scalable management of personal genomic data  J.Club

2013-01:
09 հ Integrative analysis of association between gene expression and genomic features  TopicSem
16 Knowledge bootstrapping: A graph-based integration with multi-omics data and genomic knowledge  TopicSem

2012-12:
24 Graph- and kernel-based integrative analyses of multi-layers of heterogeneous genomic data ( ϻ)  TopicSem

2012-11:
14 Aplication of pharmacogenomic knowledge to clinic  SysBiol

2012-09:
10 հ Integrative effect of genomic features on gene expression traits  TopicSem
12 Graph-based integration with gene expression and genomic knowledge (Validation results)  TopicSem
19 MedCassandra : Personalized ADR ranking forecast system based on personal genomic variation.  TopicSem
22 Identification of chemogenomic features from drug-target interaction networks using interpretable classifiers.     J.Club

2012-08:
18 Identifying aberrant pathways through integrated analysis of knowledge in pharmacogenomics     J.Club
25 The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups     J.Club

2012-07:
16 Graph-based integration with heterogeneous genomic data and genomic knowledge  TopicSem

2012-06:
02 ȭ Behavior-specific changes in transcriptional modules lead to distinct and predictable neurogenomic states     J.Club
16 A pharmacogenomic method for individualized prediction of drug sensitivity     J.Club
20 Graph-based integration with heterogeneous genomic data and genomic knowledge  TopicSem
25 MedCassandra : Personalized ADR ranking forecast system based on personal genomic variation  TopicSem

2012-05:
25 Rocky The global impact of genomic variations on miRNAs and their regulatory genes using whole genome sequencing data in human cancer  Seminar
25 Graph based integration with genomic data and genomic knowledge  Seminar
25 Prioritization of adverse drug reaction susceptibility based on personal genomic variants  Seminar

2012-04:
02 Graph-based integration with heterogeneous genomic data and genomic knowledge  TopicSem
04 Naive statistic analysis 1000genome in Pharmacogenomics  TopicSem
04 Summary of pharmacogenomics  SysBiol
25 Graph-based integration with heterogeneous genomic data and genomic knowledge  TopicSem

2012-03:
14 Summary of pharmacogenomic research  SysBiol
19 Hapmap data processing for analysis in pharmacogenomics  TopicSem

2012-02:
07 Mining drug-drug interaction using annotated pharmacogenomic phenotype and MBR data  Seminar
15 Pharmacogenomics in world  TopicSem
18 Using text to build semantic networks for pharmacogenomics     J.Club

2012-01:
11 Finding Drug-Drug Interaction using Pharmacogenomic Phenotype  TopicSem
15 Review:OMIM(Tools for genomic analysis of a catalogued gene)  xMutant
17 Rocky Classification of renal cell carcinoma subtypes based on gene expression data and mapping genomic variation to NGS data  MAInfo

2011-12:
01 Rocky Comprehensive Analysis of Genetic Regulatory Network Regulators and Drugs using Gene Expression Profiles incorporating Genomic Variations  xMutant
06 Pharmacogenomic Phenotype  Seminar
12 Integration genomic data and genomic knowledge for cancer clinical outcome prediction  TopicSem
13 Rocky Mapping of genomic variation in miRNA and its binding sites using whole genome sequencing data  MAInfo
14 Summary of SNUBI pharmacogenomic test  TopicSem
21 Plan for Pharmacogenomic phenotype  SysBiol
28 Finding Drug-Drug interaction using pharmacogenomic phenotype  SysBiol

2011-11:
01 Rocky Global mapping of genomic variations on microRNAs, target genes, TFBS, RNA binding proteins with variant knowledgebase  MAInfo
08 The structure of disease-etiology database on the epigenomic layer  MAInfo
09 Integration genomic data and genomic knowledge for cancer clinical outcome prediction  TopicSem
14 Pharmacogenomic test using VAAST  TopicSem
17 Rocky Global map of genomic variations on microRNAs, target genes, TFBS, RNA binding proteins using variant knowledgebase to construct a multi-dimensional genetic regulatory network   xMutant
19 Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles     J.Club
22 ̼ Genomic similarity in population  MAInfo
22 Phenotypic signature using genomic variant annotation on semantic network.   SysBiol
23 Phenotypic signature using genomic variant annotation on semantic network.  TopicSem

2011-10:
04 Rocky Detection of genomic variations for microRNA and its target sites  MAInfo
06 Rocky Global impact on genomic variations in microRNAs, target genes and drug relationship  xMutant
11 The network of disease-association with etiological factors on the epigenomic layer.  MAInfo
12 Pharmacogenomics annotation seminar review  SysBiol
13 Pharmacogenomic annotation  Seminar
19 Integration genomic data and genomic knowledge for cancer clinical outcome prediction   TopicSem
22 Generating Genome-Scale Candidate Gene Lists for Pharmacogenomics      J.Club
26 Pharmacogenomics analysis for unmapped variants  TopicSem

2011-09:
27 Rocky Analysis of genomic variation in miRNA and its binding sites using whole genome sequencing data  MAInfo
28 Pharmacogenomics annotation test and scoring idea  TopicSem
28 Future process and review in pharmacogenomics  SysBiol

2011-08:
20 ̼S Extensive genomic and transcriptional diversity identified through massively parallel DNA and RNA sequencing of eighteen Korean individuals     J.Club
27 Automated validation of genetic variants from large databases ensuring that variant references refer to the same genomic locations     J.Club
30 Applying Preventive Genomic Medicine in Clinical Practice  BioEMR

2011-07:
26 Rocky Analysis of genomic variation in miRNA and its binding sites using whole genome sequencing data  MAInfo
27 Graph and kernel-based integrative analyses of multi-layers of heterogeneous genomic data  TopicSem

2011-06:
20 How to measure inter-relationship between different layers of genomic data? [Progress in miRNA-gene expression data]   TopicSem
21 Rocky Framework for genomic variation discovery in miRNA and its binding sites from NGS data  MAInfo

2011-05:
02 How to measure inter-relationship between different layers of genomic data? [Progress in miRNA-gene expression data]  TopicSem
03 introduction of metagenomics  MAInfo
18 ۿ Multistep Carcinogenesis and Genomic Distance  TopicSem
23 How to measure inter-relationship between different layers of genomic data? [Progress in miRNA-gene expression data]   TopicSem

2011-04:
04 ۿ GO Term-Guided Genomic Distance between Two Individuals  TopicSem
11 How to measure inter-relationship between sample features belonging to different layers of genomic data?  TopicSem
16 Detecting Cancer Gene Networks Characterized by Recurrent Genomic Alterations in a Population     J.Club
25 ۿ Correlation between Tumor Progression and Cancer-to-Normal Genomic Distance  TopicSem

2011-03:
02 Contribution of Genomic Variants to Human Phenotypes in Functional Genomics  TopicSem
09 ۿ Development of Measurement of Genomic Similarity between Human Individuals  TopicSem

2011-02:
16 ۿ B & T Cell Metagenomics and Clinical Applications  TopicSem
21 Plan for integration with inter-relationship between sample features belonging to different layers of genomic data  TopicSem

2011-01:
26 ̼ miRNA-mRNA pairing relationship ? genomic locations and co-transcriptomics data set  TopicSem

2010-12:
15 Interpretation of high-throughput genomic data using integrated biological pathway resources and biomedical knowledge  TopicSem

2010-11:
17 Analysis of genomic physical characterization on perturbation sensitivity of a gene  TopicSem
22 ۿ Metagenomics Approach to Recombinants Profiling of T and B Cells  Seminar
22 Review on genomic rearrangement in cancer  Seminar

2010-10:
02 ̼S ArrArrayExpress update from an archive of functional genomics experiments to the atlas of gene expression     J.Club

2010-09:
11 Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis     J.Club
29 Analysis of genomic physical characterization on perturbation sensitivity of genes  TopicSem

2010-05:
01 IntOGen: integration and data mining of multidimensional oncogenomic data     J.Club
31 ۿ Annotation of Individual Human Genomic DNAs  Seminar

2010-04:
02 A metadata approach for clinical data management in translational genomics studies in breast cancer.  BioEMR
09 The Role of Genomics in the Identification, Predication, and Prevention of Biological Threats  BioEMR
24 A metadata approach for clinical data management in translational genomics studies in breast cancer.     J.Club

2010-02:
09 ̼S NCBI GEO: archive for high-throughput functional genomic data     xMutant

2010-01:
16 A statistical framework for genomic data fusion     J.Club

2009-12:
30 A graph-based integration of multidimensional cancer genomics data  Seminar

2009-11:
02 Integration of multidimensional genomic data (Databasing TCGA data)  Seminar
21 Genomic signatures to guide the use of chemotherapeutics     J.Club

2009-09:
03 Genomic coordinate overlapping similarity in mutually llinked set  Seminar
26 Pharmacogenomics 2009 Review  J.Club

2009-08:
22 Instrumenting the health care enterprise for discovery research in the genomic era     J.Club

2009-07:
16 Developing a database for integrative genomics (application in genetical genomics)  Seminar

2009-06:
08 Integration of multidimensional genomic data: Databasing multiple types of annotations  Seminar
29 Xperanto-SNP: A web-based integrated management system for genetical genomics (Adding DACE module)  Seminar

2009-05:
18 Applying Spatial indexing on genomic coordinate data  Seminar
23 In Vitro Analysis of Integrated Global High-Resolution DNA Methylation Profiling with Genomic Imbalance and Gene Expression in Osteosarcoma     J.Club
25 Integration of multidimensional genomic data: Schematic overview  Seminar

2009-03:
07 GenomeGraphs: integrated genomic data visualization with R     J.Club

2009-02:
07 SIGMA2: A system for the integrative genomic multi-dimensilnal analysis of cancer genomes, epigenomes, and transcriptomes     J.Club

2009-01:
17 KEGG spider: interpretation of genomics data in the context of the global gene metabolic network       J.Club
17 ̼ Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer     J.Club

2008-11:
22 MD-SeeGH: a platform for integrative analysis of multi-dimensional genomic data     J.Club

2008-10:
25 Integrative Genomic Analysis  J.Club

2008-08:
28 CelMAP: genomic and mRNA sequence  Seminar

2008-07:
05 A semantic grid infrastructure enabling integrated access and analysis of multilevel biomedical data in support of postgenomic clinical trials on cancer.     J.Club

2008-06:
28 ̼ Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer     J.Club

2008-05:
17 The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge     J.Club

2008-01:
25 Progress in Pharmacogenomics project [๰ü] Seminar

2007-12:
08 Genomic analysis of human microRNA transcripts       J.Club
14 Comparison of genomic structure between intronic and intergenic miRNAs  Seminar

2007-10:
06 Identifying Genomic Regulators of Set-Wise Co-Expression (presentation for BIBE 2007 )  J.Club

2007-08:
11 Cancer Genomics Object Model : An Object Model for Cancer Research using Multiple Functional Genomics Data  J.Club
17 Cancer Genomics Object Model : An Object Model for Cancer Research using Multiple Functional Genomics Data  Seminar

2007-07:
14 A genomic code for nucleosome positioning     J.Club
21 Evidence of spatially bound gene regulation in Mus musculus: decreased gene expression proximal to microRNA genomic location       J.Club

2007-03:
03 Integrating domain knowledge with statistical and data mining methods for high density genomic SNP disease association analysis     J.Club
24 High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping.       J.Club

2007-01:
03 Identifying genomic locus which affects multiple gene sets.  Seminar
20 ChromoScan: a scan statistic application for identifying chromosomal regions in genomic studies [scan statisticsSNP]      J.Club

2006-12:
13 Complex trait analysis using set-wise genetical genomics approach ( ǥ final)  Seminar
16 Finding function: evaluation methods for functional genomic data.       J.Club

2006-10:
28 Normalization procedures and detection of linkage signal in genetical-genomics experiments.       J.Club

2006-09:
25 Inferring Causal Association among Pathways (ICAP) by Genetical Genomics approach  Seminar

2006-07:
03 The graPT: Genomic inteRpreter About Predictive Toxicology     Seminar

2006-06:
09 An integrative genomics approach to infer causal associations between gene expression and disease [genetical genomics]      J.Club

2006-05:
06 Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. [genetical genomics]      J.Club
13 Data integration and genomic medicine [genomicmedicinedata integration]      J.Club
23 Finding gene modulator via Genetical Genomics approach [genetical genomics] BioEMR

2006-04:
14 Analysis plan for "Genetic Analysis Workshop" data. [genetical genomics] MAInfo

2006-03:
07 Research plan (about toxicogenomics meta DB)   BioEMR

2006-02:
09 Xperanto-Tox: strategy for data modeling toxicogenomics experiment   BioEMR

2005-12:
01 Xperanto-Tox: Integration of Xperanto and Xperanto-TMA for toxicogenomics   BioEMR
05 Comparative Genomics for Orientia  Seminar

2005-11:
02 Genetical Genomics  MAInfo
10 Cancer Genomics Object Model :An Object Model for Cancer Research using Functional Genomics Data  BioEMR
12 α Assessing the limits of genomic data integration for predicting protein networks       J.Club
15 Cancer Genomics Object Model :An Object Model for Cancer Research using Functional Genomics Data  xMutant
29 Cancer Genomics Object Model :An Object Model for Cancer Research using Functional Genomics Data  xMutant

2005-10:
06 A Framework for storing various biological material and multiple functional genomics data : an application in cancer genomics data  BioEMR
11 Cancer Genomics Object Model: An Object Model for Cancer Research using functional genomics data  xMutant
13 Cancer Genomics Object Model (progress)   BioEMR
24 "Developing a data model for integrative analysis of DNA microarray, Tissue microarray and arrayCGH for cancer genomics research"  Seminar

2005-09:
15 A Framework for storing various biological material information and functional genomics data (Feasibility Study)  BioEMR

2005-08:
01 Review of toxicogenomics  Seminar
06 Visualizing information across multidimensional post-genomic structured and textual databases     J.Club
09 Existing and emerging toxicogenomics databases  xMutant
18 A Framework for storing various biological material information and functional genomics data  BioEMR
23 Toxicogenomic issues of microarray experiment (review)  xMutant

2005-07:
02 ¼ Supervised enzyme network inference from the integration of genomic data and chemical information [vertkernel]      J.Club
30 ѹ̷ Visualization-based discovery and analysis of genomic aberrations in microarray data       J.Club

2005-06:
11 Standardization initiatives in the (eco)toxicogenomics domain: a review       J.Club

2005-04:
30 Genomic Messaging System and DNA Mark-Up Language for Information-Based Personalized Medicine with Clinical and Proteome Research Applications       J.Club

2005-03:
04 Finding human SNPs miRNA genomic position related  xMutant
31 Cancer Genomics Object Model   BioEMR

2005-02:
26 Implementation of Cancer Genomics Object Model [ClinInfo] Seminar

2005-01:
17 ¼ GenRate: A Generative Model That Finds and Scores New Genes and Exons in Genomic Microarray Data [PSB]    J.Club
18 Cancer Genomics Object Model(2)  BioEMR

2004-12:
27 ѹ̷ Detection of low level genomic alterations by comparative genomic hybridization based on cDNA micro-arrays       J.Club

2004-11:
12 ȭ Clinical-Genomic integration within CDA - INTRO.  xMutant
13 ѹ̷ Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma       J.Club
23 Guideline and web application for Microarray Experiment in Oncogenomics  BioEMR

2004-10:
29 PharmacoGenomics ɺо Ȳ  xMutant

2004-08:
28 An object model and database for functional genomics.       J.Club

2004-07:
10 How (not) to protect genomic data privacy in a distributed network: using trail re-identification to evaluate and design anonymity protection systems.       J.Club

2004-06:
05 ArrayTrack.Supporting Toxicogenomic Research at the U.S. Food and Drug Administration National Center for Toxicological Research       J.Club

2004-05:
15 GoMiner: a resource for biological interpretation of genomic and proteomic data       J.Club

2003-10:
04 α Comparing protein abundance and mRNA expression levels on a genomic scale       J.Club

2003-05:
27 (H) Visualizing Genomic Data Microarrays  Seminar

2002-05:
09 XML documentation of biopathways and their simulations in Genomic Object Net       J.Club

2002-04:
23 Prediction of probable genes by Fourier analysis of genomic sequences       J.Club

2002-03:
28 Identification of Genes in Human Genomic DNA  Seminar

-:
[Review] Implementing Genomic Clinical Decision Support for Drug-Based Precision Medicine  BioEMR
A disease-drug database to support drug prescribing based on patient pharmacogenomics test results  SysBiol
The Comparative Toxicogenomics Database  SysBiol
전예진 type of pharmacogenomic evidence and limitation  SysBiol
Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle  SysBiol
type of pharmacogenomic evidence and limitation  SysBiol
Whole-genome sequencing of rare disease patients in a national healthcare system - Genomics England 100,000 genomes project  SysBiol

powered by SNUBI